Succinamide inhibitors of IL-1β converting enzyme

Bibliography

• THORNBERRY NA: The caspase family of cysteine proteases. Br. Med. Bull. (1997) 53:478–490.
   PubMed Web of Science ®Google Scholar
• DINARELLO CA: Interleukin-18. Methods (1999) 19(1):121–132.
   PubMed Web of Science ®Google Scholar
• •A comprehensive review about IL-18.
   Google Scholar
• SCHONBECK U, MACH F, LIBBY P: Generation of biologically active IL-113 by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-113 processing. J Immunol. (1998) 161 (7):3340–3346.
   PubMedGoogle Scholar
• FANTUZZI G, DINARELLO CA: Interleukin-18 and interleukin-1P: two cytokine substrates for ICE (caspase-1). j Clin. Immunol. (1999) 19(0:1–11.
   PubMedGoogle Scholar
• FANTUZZI G, KU G, HARDING MW et al: Response to local inflammation of IL-1 n-converting enzyme-deficient mice. J Immunol. (1997) 158(01818–1824.
   PubMed Web of Science ®Google Scholar
• GU Y, KUIDA K, TSUTSUI H et al.: Activation of interferon-y inducing factor mediated by interleukin-113 converting enzyme. Science (1997) 275 (5297):206–209.
   PubMed Web of Science ®Google Scholar
• GHAYUR T, BANERJEE S, HUGUNIN M et al.: Caspase-1 processes IFN-y-inducing factor and regulates LPS-induced IFN-y production. Nature (1997) 386 (6625):619–623.
   PubMed Web of Science ®Google Scholar
• TSUTSUI H, KAYAGAKI N, KUIDA K et al.: Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity (1999) 11 (3):359–367.
   PubMedGoogle Scholar
• DINARELLO CA: IL-18: a TH1-inducing, proinflamma-tory cytokine and new member of the IL-1 family. J Allergy Clin. Immunol. (1999) 103 (1[Pt1]):11–24.
   Google Scholar
• •A comprehensive review about IL-18.
   Google Scholar
• DINARELLO CA: Biologic basis of interleukin-1 in disease. Blood (1996) 87(6):2095–2147.
   PubMed Web of Science ®Google Scholar
• LEBEL-BINAY S, BERGER A, ZINZINDOHOUE F et al.: Interleukin-18: biological properties and clinical implications. Eur. Cytokine Netw. (2000) 11 (1) :15–26.
   PubMed Web of Science ®Google Scholar
• •A review of a role of IL-18 in various diseases.
   Google Scholar
• AKIRA S: The role of IL-18 in innate immunity. Curr. Opin. Immunol. (2000) 1 2 (1) :59–63.
   Google Scholar
• FANTUZZI G, REED DA, DINARELLO CA: IL-12-induced IFN-yis dependent on caspase-1 processing of the IL-18 precursor. J Clin. Invest. (1999) 104 (6):761–767.
   PubMedGoogle Scholar
• NAKAMURA S, OTANI T, IJIRI Y, MOTODA R, KURIMOTO M, ORITA K: IFN-y-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12. j Immunol. (2000) 164 (6):3330–3336.
   PubMed Web of Science ®Google Scholar
• ZHU SG, SHENG JG, JONES RA et al.: Increased interleukin-113 converting enzyme expression and activity in Alzheimer's disease. J. Neuropathol. Exp. Neurol. (1999) 58(6):582–587.
   PubMedGoogle Scholar
• TROY CM, RABACCHI SA, FRIEDMAN WJ, FRAPPIER TF,BROWN K, SHELANSKI ML: Caspase-2 mediates neuronal cell death induced by 13-amyloid. J. Neurosci. (2000) 20(4):1386–1392.
   PubMed Web of Science ®Google Scholar
• ONA VO, LI M, VONSATTEL JP et al: Inhibition ofcaspase-1 slows disease progression in a mouse model of Huntington's disease. Nature (1999) 399 (6733):263–267.
   PubMedGoogle Scholar
• KLEVENYI P, ANDREASSEN 0, FERRANTE RJ, SCHLEICHERJR, JR., FRIEDLANDER RM, BEAL MF: Transgenic mice expressing a dominant negative mutant interleukin-113 converting enzyme show resistance to MN? n eur o to x icity. Neuroreport (1999) 10 (3):635–638.
   Google Scholar
• LI M, ONA VO, GUEGAN C et al.: Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science (2000) 288(5460335–339.
   Google Scholar
• FRIEDLANDER RM: Bio World Today. (14 April 2000).
   Google Scholar
• FURLAN R, FILIPPI M, BERGAMI A et al: Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study. J Neurol Neurosurg. Psychiatry (1999) 67(6):785–788.
   PubMed Web of Science ®Google Scholar
• JANDER S, STOLL G: Differential induction of interleukin-12, interleukin-18 and interleukin-113 converting enzyme mRNA in experimental autoim-mune encephalomyelitis of the Lewis rat. J Neuroim-munol (1998) 91 (1-2):93–99.
   PubMedGoogle Scholar
• FURLAN R, MARTINO G, GALBIATI F et al.: Caspase-1 regulates the inflammatory process leading to autoim-mune demyelination. J. tonnuno./. (1999) 163 (5):2403–2409.
   Google Scholar
• SAHA N, MOLDOVAN F, TARDIF G, PELLETIER JP, CLOUTIER JM, MARTEL-PELLETIER J: IL-113-converting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-113 and interleukin-18. Arthritis Rheum. (1999) 42 (8) :1577–1587.
   PubMedGoogle Scholar
• GRACIE JA, FORSEY RJ, CHAN WL et al: A proinflamma-tory role for IL-18 in rheumatoid arthritis. J Clin. Invest. (1999) 104(101393–1401.
   Google Scholar
• DAYER J-M: Interleukin-18, rheumatoid arthritis andtissue destruction. J. Clin. Invest. (1999) 104(10:1337–1339.
   PubMedGoogle Scholar
• •An interesting commentary on the role of IL-18 in rheuma-toid arthritis.
   Google Scholar
• WILSON KP: Structure-based inhibitors of neuronalapoptosis: caspases and JNK3. Proceedings of the 4th International Symposium on Medicinal Chemistry of Neurodegenerative Diseases. Cancun, Mexico (2000).
   Google Scholar
• MCALINDON ME, GALVIN A, MCKAIG B, GRAY T, SE WELLHF, MAHIDA YR: Investigation of the expression of IL-113 converting enzyme and apoptosis in normal and inflammatory bowel disease (IBD) mucosal macrophages. Clin. Exp. Immunol. (1999)116 (2):251–257.
   PubMedGoogle Scholar
• LIU XH, KWON D, SCHIELKE GP, YANG GY, SILVERSTEINFS, BARKS JD: Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic- brain damage. J. Cereb. Blood Flow Metab. (1999) 19(10):1099–1108.
   PubMedGoogle Scholar
• BOSSENMEYER-POURIE C, KOZIEL V, DAVAL JL: Involve-ment of caspase-1 proteases in hypoxic brain injury. effects of their inhibitors in developing neurons. Neuroscience (2000) 95(4):1157–1165.
   Google Scholar
• MORITA-FUJIMURA Y, FUJIMURA M, KAWASE M, MURAKAMI K, KIM GW, CHAN PH: Inhibition of interleukin-113 converting enzyme family proteases (caspases) reduces cold injury-induced brain trauma and DNA fragmentation in mice. J. Cereb. Blood Flow Metab. (1999) 19(6):634–642.
   PubMedGoogle Scholar
• FINK KB, ANDREWS LJ, BUTLER WE et al.: Reduction ofpost-traumatic brain injury and free radical produc-tion by inhibition of the caspase-1 cascade. Neurosci-ence (1999) 94(4):1213–1218.
   PubMedGoogle Scholar
• GROBMYER SR, ARMSTRONG RC, NICHOLSON SC et al.:Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shock. MoL Med. (1999) 5 (9):585–594.
   PubMedGoogle Scholar
• TINSLEY KW, CHENG SL, BUCHMAN TG et al.: Caspases -2, -3, -6 and -9, but not caspase-1, are activated in sepsis-induced thymocyte ap op tosis. Shock (2000) 13(1):1–7.
   PubMed Web of Science ®Google Scholar
• ASTIZ ME, RACKOW EC: Septic shock. Lancet. (1998) 351(91101501–1505.
   Google Scholar
• WEIGHARDT H, HEIDECKE CD, EMMANUILIDIS K et al.:Sepsis after major visceral surgery is associated with sustained and interferon-y-resistant defects of monocyte cytokine production. Surgery (2000) 127(3):309–315.
   PubMedGoogle Scholar
• GUICHON A, ZYCHLINSKY A: Apoptosis as a trigger ofinflammation in Shigella-induced cell death. Biochem. Soc. Trans. (1996) 24(4):1051–1054.
   PubMedGoogle Scholar
• HILBI H, CHEN Y, THIRUMALAI K, ZYCHLINSKY A: Theinterleukin 113-converting enzyme, caspase 1, is activated during Shigella flexneri-induced apoptosis in human monocyte-derived macrophages. Infect. Immun. (1997) 65(12):5165–5170.
   PubMedGoogle Scholar
• TSUTSUI H, MATSUI K, OKAMURA H, NAKANISHI K: Pathophysiological roles of interleukin-18 in inflam-matory liver diseases. Immunol Rev. (2000) 174:192–209.
   PubMed Web of Science ®Google Scholar
• FRIEDLANDER RM, YUAN J: ICE,neuronalapoptosis andneurodegeneration. J. Cell Death Differ. (1998) 5 (10):823–831.
   PubMedGoogle Scholar
• FRIEDLANDER RM, GAGLIARDINI V, HARA H et al.:Expression of a dominant negative mutant of interleukin-113 converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. (1997) 185:933–940.
   PubMed Web of Science ®Google Scholar
• HARA H, FINK K, ENDRES M et al.: Attenuation oftransient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J Cereb. Blood Flow Metab. (1997) 17:370–375.
   PubMed Web of Science ®Google Scholar
• SCHIELKE GP, YANG G-Y, SHIVERS BD, BETZ AL: ischemic brain injury in Interleukin-113 converting enzyme-deficient mice. J. Cereb. Blood Flow Metab. (1998) 18:180–185.
   PubMedGoogle Scholar
• SHIVERS BD, BOXER PA, KEANE KM et al.: Contribution of the ICE family to neur odegeneration. Ann. NY Acad. Sci. (1998) 840:59–64.
   PubMed Web of Science ®Google Scholar
• REZVANI M, BARRANS JD, DAI KS, LIEW CC: Apoptosis-related genes expressed in cardiovascular develop-ment and disease: an EST approach. Cardiovasc. Res. (2000) 45 (3):621–629.
   PubMedGoogle Scholar
• WANG J, LENARDO MJ: Roles of caspases in apoptosis, development and cytokine maturation revealed by homozygous gene deficiencies. J. Cell Sci. (2000) 113 (Part 5):753–757.
   Google Scholar
• GRACZYK PP: Caspase inhibitors-a chemist's perspec-tive. Restor. Neurol. Neurosci. (1999) 14:1–23.
   PubMedGoogle Scholar
• •A review of literature (including patents) concerning caspase inhibitors.
   Google Scholar
• DOLLE RE, HOYER D, PRASAD CV et al.: P1 Aspartate-based peptide a-((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of Interleukin-1n-converting enzyme. J. Med. Chem. (1994) 37:563–564.
   PubMed Web of Science ®Google Scholar
• DOLLE RE, SINGH J, WHIPPLE D et al.: Aspartyla-((diphenylphosphinyl)oxy)methyl ketones as novel inhibitors of interleukin-113 converting enzyme. Utility of the diphenylphosphinic acid leaving group for the inhibition of cysteine proteases. J Med. Chem. (1995) 38:220–222.
   Google Scholar
• OSHIKAWA K, SHI F, RAKHMILEVICH AL, SONDEL PM,MAHVI DM, YANG NS: Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18 and IL-113 converting enzyme cDNA. Proc. Natl. Acad. Sci. USA (1999) 96(23):13351–13356.
   PubMedGoogle Scholar
• NAGAI H, HARA I, HORIKAWA T et al.: Antitumor effectson mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18. CancerInvest. (2000) 18(3) :206–213.
   Google Scholar
• KIKUCHI T, AKASAKI Y, JOKI T, ABE T, KURIMOTO M,OHNO T: Antitumor activity of interleukin-18 on mouse glioma cells. J Immunother. (2000) 23 (2) :184–189.
   PubMedGoogle Scholar
• OSAKI T, HASHIMOTO W, GAMBOTTO A et al.: Potentantitumor effects mediated by local expression of the mature form of the interferon-y inducing factor, interleukin-18 (IL-18). Gene Ther. (1999) 6(5):808–815.
   PubMed Web of Science ®Google Scholar
• ARAI N, AKAMATSU S, ARAI S et al.: Interleukin-18 incombination with IL-2 enhances natural killer cell activity without inducing large amounts of IFN-y in vivo. J. Interferon Cytokine Res. (2000) 20(2)217–224.
   Google Scholar
• CAO R, FARNEBO J, KURIMOTO M, CAO Y: Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB (1999) 13(15)2195–2202.
   Google Scholar
• DYBING JK, WALTERS N, PASCUAL DW: Role of endoge-nous interleukin-18 in resolving wild-type and Salmonella typhimurium infections. Infect. Immun. (1999) 67(12):6242–6248.
   PubMedGoogle Scholar
• ZEUNER A, ERAMO A, PESCHLE C, DE MARIA R: Caspaseactivation without death. Cell Death Differ. (1999) 6(10:1075–1080.
   PubMedGoogle Scholar
• •A recent review about the function of caspases.
   Google Scholar